Filter
1560
Text search:
medicines
financing
Featured
Recommendations
132
New Publications
486
Language
Document type
No document type
855
Studies & Reports
320
Guidelines
140
Strategic & Response Plan
126
Manuals
69
Fact sheets
21
Situation Updates
12
Training Material
7
Resource Platforms
4
Infographics
4
Brochures
2
Countries / Regions
Global
105
Kenya
65
Uganda
46
Sierra Leone
43
Liberia
41
Ethiopia
37
Ghana
37
Africa
37
Western and Central Europe
36
India
35
Myanmar / Burma
34
Nigeria
33
Zambia
29
Ukraine
29
Bangladesh
26
Rwanda
25
South Africa
25
Malawi
25
Nepal
23
Tanzania
23
Namibia
20
Eastern Europe
20
Latin America and the Carribbean
19
Asia
15
Mozambique
13
Congo, Democratic Republic of
12
Philippines
12
East and Southern Africa
12
Cambodia
11
Zimbabwe
10
Indonesia
10
Lesotho
10
West and Central Africa
10
Middle East and North Africa
10
South–East Asia Region
10
Guinea
9
Botswana
9
Senegal
7
Cameroon
7
Haiti
7
Syria
7
Burkina Faso
6
Eastern Europe and Central Asia
6
Venezuela
6
Pakistan
5
Thailand
5
Eswatini/ Swaziland
5
Vietnam
5
Somalia
4
Sudan
4
Benin
4
Western Pacific Region
4
Tajikistan
4
Russia
4
North America
4
South Sudan
3
Jordan
3
Afghanistan
3
North Macedonia
3
Paraguay
3
Laos
3
Georgia
3
Gambia
2
China
2
Central African Republic
2
Ecuador
2
Bolivia
2
Libya
2
Yemen
2
Palestine
2
Albania
2
Southern Africa
2
Timor Leste/ East Timor
2
Qatar
2
Moldova
2
Kyrgyzstan
2
Jamaica
2
Mali
1
Saudi Arabia
1
Iraq
1
Germany
1
Lebanon
1
Egypt
1
Chad
1
Papua New Guinea
1
Peru
1
Brazil
1
Switzerland
1
Colombia
1
Sri Lanka
1
Chile
1
Other region
1
Djibouti
1
Armenia
1
Mongolia
1
Bulgaria
1
Iran
1
Uzbekistan
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
694
Public Health
113
Clinical Guidelines
80
Women & Child Health
60
Key Resources
48
Pharmacy & Technologies
10
Capacity Building
7
Toolboxes
HIV
144
TB
130
COVID-19
107
AMR
63
Health Financing Toolbox
60
Mental Health
53
Global Health Education
47
Pharmacy
46
Planetary Health
35
NCDs
31
Caregiver
29
Disability
28
Malaria
28
Conflict
25
NTDs
24
Ebola & Marburg
23
Rapid Response
18
Refugee
12
2.0 Rapid Response
11
Natural Hazards
10
Polio
6
Cholera
5
Zika
3
Specific Hazards
1
Social Ethics
1
Prices people pay for medicines.
R4D conducted a thorough desk review and qualitative fiscal space analysis, 19 interviews about financing for the three diseases and the extent of alignment between public financial management systems and health policy objectives, and a validation w
...
The report explores strategies for sustaining the country’s responses to the three diseases and eventually transitioning away from external funding and programmatic support. It takes stock of Kenya’s health financing landscape and identifies opp
...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while f
...
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Thefirst report on Latin America and the Carribean presents key indicators on health and health systems in 33 Latin America and the Caribbean countries. . Analysis is based on the latest comparable data across almost 100 indicators including equity, health status, determinants of health, health car
...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affor
...
Governments have dedicated a pivotal role to the private sector in the implementation and financing of the 2030 Agenda and the SDGs. This has pushed a turn towards the private sector, the promotion of multi-stakeholder partnerships between public an
...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situa
...
Early-warning indicators to prevent stock-outs and overstocking of antiretroviral, antituberculosis and antimalaria medicines.
Strengthening supply chains to meet the growing demand for family planning will require systems diagnostics, supply chain redesign or adjustments, strategically located storage and distribution systems, adequate staffing and training, and better information about inventory and
...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant
...
This National Health Policy has 5 objectives, namely
i. To strengthen the healthcare delivery system to be resilient
ii. To encourage the adoption of healthy lifestyles
iii. To improve the physical environment
iv. To improve the socio-economic status of the population
v. To ensure sustainable
...
The ongoing COVID-19 pandemic has shown that public financial management (PFM) should be an integral part of the response. Effectiveness in financing the health response depends not only on the level of funding but also on the way public funds are a
...
IN THE AMOUNT OF SDR 21.8 MILLION (US$30 MILLION EQUIVALENT) WITH AN ADDITIONAL GRANT FROM THE GLOBAL FINANCING FACILITY (GFF) IN THE AMOUNT OF US$ 10 MILLION TO THE DEMOCRATIC REPUBLIC OF CONGO FOR A HUMAN DEVELOPMENT SYSTEMS STRENGTHENING PROJECT
...
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-
...
Third edition.
The main changes within the third edition of the JEE tool include the split of the technical area National legislation, policy, and financing into two technical areas (Legal instruments and
...
